Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chattem Chemicals is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) and performance chemicals based in Chattanooga, Tennessee. As a wholly-owned subsidiary of Sun Pharmaceutical Industries, the company plays a critical role in the global supply chain for controlled substances and specialty chemical intermediates. Their product portfolio includes high-potency APIs such as methadone, buprenorphine, and fentanyl, alongside various aluminum-based compounds used in antacids and antiperspirants. The company operates a US FDA-registered facility that adheres to strict Current Good Manufacturing Practices (cGMP) and DEA regulations for Schedule II through V substances. Beyond API production, Chattem Chemicals offers contract manufacturing and development services (CDMO), supporting clients from process development through commercial-scale synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chattem Chemicals.